In the tumor environment, sialyl–Tn (sTn) antigens, sialyl Lewis x (sLex) antigen, GD2 disialoganglioside with the sialyl Lewis A epitope (sLea) and sTn epitope, have been used for cancer biomarkers and treatment [89]. The gene discussed is EEF1A2; the disease is cancer.